Latest American College of Medical Genetics Stories

BETHESDA, Md., April 17, 2013 /PRNewswire-USNewswire/ -- The U.S. Supreme Court heard arguments Monday in a case seeking to invalidate patents on two genes associated with hereditary breast and ovarian cancer. The American College of Medical Genetics and Genomics (ACMG) was one of the first plaintiffs to sign onto this historic legal case. ACMG was also the first professional medical association to establish a position against gene patenting. In its 1999 ACMG Position Statement on...

SAN JOSE, CA, April 6, 2013 /PRNewswire/ - The American College of Medical Genetics (ACMG) issued a position statement to support the use of non-invasive prenatal screening (NIPS) in women with singleton pregnancies. The statement can be found at this link: http://www.acmg.net/docs/nips-GiM_galley_text_130301.pdf (Logo: http://photos.prnewswire.com/prnh/20130225/SF62999LOGO) The statement clearly emphasizes NIPS as a screening, and not diagnostic, test. It goes on to highlight...

BETHESDA, Md., March 28, 2013 /PRNewswire-USNewswire/ -- The American College of Medical Genetics and Genomics (ACMG) recently announced that six new directors have been elected to its Board. The Board of Directors are active participants in serving as advocates for the ACMG and for advancing its policies and programs. "It's a momentous time in medical genetics and genomics. We are excited to add these exemplary individuals to our Board," said Michael S. Watson, PhD, FACMG, ACMG...

BETHESDA, Md., March 28, 2013 /PRNewswire-USNewswire/ -- Gail E. Herman, MD, PhD, FACMG of Columbus, Ohio, is the new president of the American College of Medical Genetics and Genomics (ACMG), the national professional organization for clinical genetics professionals. Dr. Herman takes over from Wayne W. Grody, MD, PhD, of Los Angeles, Calif., who completed his two-year term at the 2013 Annual Clinical Genetics Meeting in Phoenix, AZ, in March. "I've been doing clinical genetics...

BETHESDA, Md., March 6, 2013 /PRNewswire-USNewswire/ -- The American College of Medical Genetics and Genomics (ACMG) has just launched a smartphone mobile application "app" called ACMG 2013 to give attendees a convenient and comprehensive way to navigate the 2013 ACMG Annual Clinical Genetics Meeting and a convenient method to receive and utilize program, speaker and exhibitor information before, during and after the Annual Meeting. The ACMG mobile app is available for iPhone and...

BETHESDA, Md., March 6, 2013 /PRNewswire-USNewswire/ -- The ACMG Foundation for Genetic and Genomic Medicine and genetics professionals from around the world will be on hand to present bicycles to local Phoenix-area children from the Muscular Dystrophy Association (MDA) as part of the ACMG's 2013 Annual Clinical Genetics Meeting and Conference in Exhibit Hall BCD of the Phoenix Convention Center, Friday, March 22 at 10 a.m. This is the third annual ACMG Foundation Day of Caring and...

Online Genetic Testing Marketplace Offers Platform to Search, Compare and Order Tests NASHVILLE, Tenn., March 5, 2013 /PRNewswire/ -- NextGxDx Inc., which provides an online genetic testing marketplace for healthcare professionals and hospitals, today announced the successful closing of a $1 million, angel-funded, convertible note round. The company's capital goal was fully met with the Series A2 financing, with NextGxDx welcoming several new investors alongside existing shareholders...

BETHESDA, Md., Jan. 7, 2013 /PRNewswire-USNewswire/ -- The ACMG Foundation for Genetic and Genomic Medicine has been awarded $50,000 for the David L. Rimoin Memorial Fund from the Los Angeles-based Sports Spectacular organization. This donation will support the David L. Rimoin Lifetime Achievement Award as well as provide for genetics training for up-and-coming medical geneticists. The late Dr. David Rimoin was a world-renowned geneticist whose work was supported by the Cedars-Sinai...

BETHESDA, Md., Nov. 7, 2012 /PRNewswire-USNewswire/ -- The American College of Medical Genetics and Genomics (ACMG) released a new official Position Statement on the Public Disclosure of Clinically Relevant Genome Variants. This important new statement addresses the problems resulting from gene patent monopolies that have allowed some to develop proprietary databases of the clinical meaning of the variants in particular genes. Michael S. Watson, Ph.D., FACMG, executive director of...

SAN DIEGO and CAMBRIDGE, Mass., Oct. 22, 2012 /PRNewswire/ -- Good Start Genetics®, a leading and innovative molecular diagnostics company offering the new gold standard for genetic disease carrier screening, announced today that it has launched an expanded menu of testing services. The announcement, made at this week's annual meeting of the American Society for Reproductive Medicine (ASRM), means that Good Start Genetics' screening service, GoodStart Select(TM), now offers...